The dataset for the interim analysis includes non-fatal and terminal cardiac events from the first 270 of the anticipated 600 patients to be included in this ongoing trial. The IDMC will review and interpret the results of the interim analysis and provide recommendations shortly.
They have mentioned results will be provided shortly. Do you know it will take days or weeks to disclose the results
- Forums
- ASX - By Stock
- Ann: Process Initiated For CHF P3 Interim Analysis
The dataset for the interim analysis includes non-fatal and...
Featured News
Add MSB (ASX) to my watchlist
(20min delay)
|
|||||
Last
$1.62 |
Change
-0.165(9.27%) |
Mkt cap ! $1.909B |
Open | High | Low | Value | Volume |
$1.72 | $1.74 | $1.58 | $7.896M | 4.780M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
14 | 29990 | $1.61 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.62 | 26505 | 8 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
5 | 1918 | 1.610 |
12 | 32534 | 1.605 |
13 | 132611 | 1.600 |
11 | 157586 | 1.595 |
13 | 116078 | 1.590 |
Price($) | Vol. | No. |
---|---|---|
1.615 | 3160 | 4 |
1.620 | 13152 | 7 |
1.625 | 24325 | 6 |
1.630 | 73402 | 23 |
1.635 | 3122 | 1 |
Last trade - 12.43pm 15/11/2024 (20 minute delay) ? |
Featured News
MSB (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Will Souter, CFO
Will Souter
CFO
Previous Video
Next Video
SPONSORED BY The Market Online